Detalles de la búsqueda
1.
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
Cancer Immunol Immunother
; 73(8): 160, 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850335
2.
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123.
Int J Mol Sci
; 25(3)2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38338733
3.
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients.
J Transl Med
; 21(1): 318, 2023 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37170241
4.
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
Ann Hematol
; 101(4): 781-788, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35150296
5.
The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
Cancer Immunol Immunother
; 70(7): 1797-1809, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33386466
6.
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.
J Transl Med
; 19(1): 489, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34852840
7.
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma.
Br J Haematol
; 184(4): 594-604, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30426471
8.
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
Br J Haematol
; 166(1): 118-29, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24673727
9.
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.
Br J Haematol
; 160(2): 207-15, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23167437
10.
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.
Blood
; 118(24): 6353-61, 2011 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21998207
11.
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
Br J Haematol
; 156(2): 234-44, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22098541
12.
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation.
Infect Agent Cancer
; 17(1): 41, 2022 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922822
13.
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
Cancers (Basel)
; 14(23)2022 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497328
14.
Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
J Cell Physiol
; 226(8): 2131-8, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21520065
15.
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.
Br J Haematol
; 154(5): 579-89, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21707585
16.
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
Eur J Haematol
; 87(6): 547-53, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21752099
17.
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
J Pathol
; 221(3): 248-63, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20527019
18.
Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab.
Infect Agent Cancer
; 16(1): 38, 2021 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34078415
19.
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers.
Cancers (Basel)
; 13(5)2021 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33669053
20.
Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive Non-Hodgkin Lymphoma.
Am J Pathol
; 175(6): 2609-17, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19893048